Europe Infection Surveillance Solutions Market Size, Share & Industry Trends Analysis Report By Product & Services (Software (On-premise and Web-based Software) and Services), By End User, By Country and Growth Forecast, 2023 - 2029
The Europe Infection Surveillance Solutions Market would witness market growth of 12.2% CAGR during the forecast period (2023-2029).
The development of analytical & infection surveillance solutions for use in the healthcare industry is aided by increased IT system capacity to undertake analytical processing in conjunction with technological improvements in IT systems. Furthermore, the healthcare industry is developing a competent workforce due to various improvements in surveillance solutions that are making it easier for personnel in clinical & healthcare settings to grasp surveillance software and its utilization.
The market is expanding due to the increasing costs of healthcare as well as the high rate of adoption of new IT systems in hospitals for maintaining electronic healthcare records (EHR). The market for infection surveillance solutions also benefits from the growing elderly population and the rising number of surgeries performed globally. In addition, healthcare information & technology (IT) businesses provide cutting-edge solutions for data management, analytics, and infrastructures that make collecting data on diseases and outbreaks easy.
This is accelerating market expansion and several advancements in surveillance solutions that help medical professionals comprehend the software and how to use it. Furthermore, the growing use of cloud-based software and the rising demand for web-based solutions or mobile platforms are further aspects that are anticipated to provide key market players with lucrative growth prospects.
The UK's medical technology industry has a yearly turnover of about $30 billion. It has a solid basis made up primarily of small to medium-sized businesses spread out over the nation, with hubs of activity in places like the Southeast of England & the Midlands. Several major U.S. manufacturers of medical equipment as well as other multinational corporations, have head offices or branches in the UK. Germany is by far the largest European market for medical technology, ranking third in the world. It is projected that these factors will aid in expanding the region's market.
The Germany market dominated the Europe Infection Surveillance Solutions Market by Country in 2022; thereby, achieving a market value of $79.1 Million by 2029. The UK market is exhibiting a CAGR of 11.1% during (2023 - 2029). Additionally, The France market would experience a CAGR of 13.1% during (2023 - 2029).
Based on Product & Services, the market is segmented into Software (On-premise and Web-based Software) and Services. Based on End User, the market is segmented into Hospitals, Long-term Care Facilities and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Oracle Corporation (Cerner Corporation), Wolters Kluwer N.V., BioMérieux S.A., Baxter International, Inc., Harris Healthcare (Constellation Software, Inc.), Securitas AB, OSI Systems, Inc. (Spacelabs Healthcare), Gojo Industries, Inc. and Merative L.P. (Francisco Partners)
Scope of the Study
Market Segments covered in the Report:
By Product & Services
Software
On-premise
Web-based Software
Services
By End User
Hospitals
Long-term Care Facilities
Others
By Country
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Companies Profiled
Becton, Dickinson and Company
Oracle Corporation (Cerner Corporation)
Wolters Kluwer N.V.
BioMérieux S.A.
Baxter International, Inc.
Harris Healthcare (Constellation Software, Inc.)
Securitas AB
OSI Systems, Inc. (Spacelabs Healthcare)
Gojo Industries, Inc.
Merative L.P. (Francisco Partners)
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Infection Surveillance Solutions Market, by Product & Services
- 1.4.2 Europe Infection Surveillance Solutions Market, by End User
- 1.4.3 Europe Infection Surveillance Solutions Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- Chapter 4. Europe Infection Surveillance Solutions Market by Product & Services
- 4.1 Europe Software Market by Country
- 4.2 Europe Infection Surveillance Solutions Market by Software Type
- 4.2.1 Europe On-premise Market by Country
- 4.2.2 Europe Web-based Software Market by Country
- 4.3 Europe Services Market by Country
- Chapter 5. Europe Infection Surveillance Solutions Market by End User
- 5.1 Europe Hospitals Market by Country
- 5.2 Europe Long-term Care Facilities Market by Country
- 5.3 Europe Others Market by Country
- Chapter 6. Europe Infection Surveillance Solutions Market by Country
- 6.1 Germany Infection Surveillance Solutions Market
- 6.1.1 Germany Infection Surveillance Solutions Market by Product & Services
- 6.1.1.1 Germany Infection Surveillance Solutions Market by Software Type
- 6.1.2 Germany Infection Surveillance Solutions Market by End User
- 6.2 UK Infection Surveillance Solutions Market
- 6.2.1 UK Infection Surveillance Solutions Market by Product & Services
- 6.2.1.1 UK Infection Surveillance Solutions Market by Software Type
- 6.2.2 UK Infection Surveillance Solutions Market by End User
- 6.3 France Infection Surveillance Solutions Market
- 6.3.1 France Infection Surveillance Solutions Market by Product & Services
- 6.3.1.1 France Infection Surveillance Solutions Market by Software Type
- 6.3.2 France Infection Surveillance Solutions Market by End User
- 6.4 Russia Infection Surveillance Solutions Market
- 6.4.1 Russia Infection Surveillance Solutions Market by Product & Services
- 6.4.1.1 Russia Infection Surveillance Solutions Market by Software Type
- 6.4.2 Russia Infection Surveillance Solutions Market by End User
- 6.5 Spain Infection Surveillance Solutions Market
- 6.5.1 Spain Infection Surveillance Solutions Market by Product & Services
- 6.5.1.1 Spain Infection Surveillance Solutions Market by Software Type
- 6.5.2 Spain Infection Surveillance Solutions Market by End User
- 6.6 Italy Infection Surveillance Solutions Market
- 6.6.1 Italy Infection Surveillance Solutions Market by Product & Services
- 6.6.1.1 Italy Infection Surveillance Solutions Market by Software Type
- 6.6.2 Italy Infection Surveillance Solutions Market by End User
- 6.7 Rest of Europe Infection Surveillance Solutions Market
- 6.7.1 Rest of Europe Infection Surveillance Solutions Market by Product & Services
- 6.7.1.1 Rest of Europe Infection Surveillance Solutions Market by Software Type
- 6.7.2 Rest of Europe Infection Surveillance Solutions Market by End User
- Chapter 7. Company Profiles
- 7.1 Becton, Dickinson and Company
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Partnerships, Collaborations, and Agreements:
- 7.1.5.2 Acquisition and Mergers:
- 7.1.5.3 Product Launches and Product Expansions:
- 7.1.6 SWOT Analysis
- 7.2 Oracle Corporation (Cerner Corporation)
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Partnerships, Collaborations, and Agreements:
- 7.2.6 SWOT Analysis
- 7.3 Wolters Kluwer N.V.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Partnerships, Collaborations, and Agreements:
- 7.3.5.2 Product Launches and Product Expansions:
- 7.4 BioMérieux S.A.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Partnerships, Collaborations, and Agreements:
- 7.4.5.2 Acquisition and Mergers:
- 7.4.5.3 Product Launches and Product Expansions:
- 7.5 Baxter International, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Partnerships, Collaborations, and Agreements:
- 7.5.5.2 Acquisition and Mergers:
- 7.6 Harris Healthcare (Constellation Software, Inc.)
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional Analysis
- 7.6.5 Recent strategies and developments:
- 7.6.5.1 Acquisition and Mergers:
- 7.7 Securitas AB
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.8 OSI Systems, Inc. (Spacelabs Healthcare)
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Gojo Industries, Inc.
- 7.9.1 Company Overview
- 7.10. Merative L.P. (Francisco Partners)
- 7.10.1 Company Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook